Non-initiation of oral anticoagulants within 30 days after diagnosis among non-valvular atrial fibrillation patients is still high in France from 2016 to 2020

Olivier Hanon; Yves Cottin; J.-C. Deharo; Jade Vadel; Barbara Roux; Catherine Collin; Henri Bonnabau; D. Guitard-Dehoux; Swati Roy; A. Saighi; F. Sedjelmaci; Professor Gregory Lip; Laurent Fauchier

doi:10.1016/j.acvd.2024.10.164

Related publications

Article2020

Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy

Professor Gregory Lip, Allison Keshishian, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Christian Klem, Lisa Rosenblatt, Jack Mardekian, Jenny Jiang, Hüseyin Yüce, Steven Deitelzweig

Article2013

Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

Article2022

Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study

Steven Deitelzweig, Allison Keshishian, Amiee Kang, Aaron Jenkins, Nipun Atreja, Patricia Schuler, Jenny Jiang, Hüseyin Yüce, Xiaoxi Sun, Professor Gregory Lip

Article2017

Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation

Maria Cristina Vedovati, Paolo Verdecchia, Michela Giustozzi, Gabriella Molini, Serenella Conti, Lucia Pierpaoli, Francesca Valecchi, Adolfo Aita, Giancarlo Agnelli, Cecilia Becattini

Article2019

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease

Inki Moon, So-Ryoung Lee, Eue-Keun Choi, Euijae Lee, Jin‐Hyung Jung, Kyungdo Han, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip